DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20170549

Effectiveness of evidence based regimen for medical abortion over conventional methods

Anitha K. Gopal, Sajini B. Sajini B., Ganamurali S., Beena Kumari R.

Abstract


Background: Medical abortion is a means of medical termination of pregnancy by drugs alone. This can be done upto 63 days using mifepristone and misoprostol tablets. For the conventional method, patient has to come to the hospital 3 times. In our study we reduced the interval between the drugs there by reducing the number of hospital visits. The objectives were to study the reduction of induction abortion interval following administration of evidence based regimen and to compare the proportion of patients developing complications in both the groups.

Methods: It was a comparative study conducted at Department of Obstetrics and Gynecology, Govermnent Medical

College Kottayam, Kerala, India from May 2015 to November 2015.

Results: The mean induction abortion interval in experimental group was 14.3 hours and in control group, it was 60.4 hours which was found to be statistically significant. Only 3 patients (7%) of experimental group had side effects whereas 12 patients. (17.4%) had side effects in the control group. Major side effects encountered were severe abdominal pain and severe bleeding per vaginum. Evidence based  regimen consist of administration of mifepristone 200mg and vaginal misoprostol 600µg 6 hours later for termination of pregnancy up to 63 days could reduce the induction abortion interval by 46 hours and had less side effects.

Conclusions: As it reduces the induction abortion Interval and complications we feel that the evidence based regimen for Medical Termination of Pregnancy is superior to the FDA approved regimen.

Keywords


Mifepristone, Misoprostol, Pregnancy, Unwanted

Full Text:

PDF

References


Sathyavathi K, Kamala Ganesh. Medical Termination of Pregnancy. IGNOU; 2008:91-104.

Verma M, Singh U, Singh N, Shankhwar P, Srivasthava D. Efficacy of misoprostol administration 24 hours after mifepristone for termination of early pregnancy. Indian J Med Sci. 2011;65(12):511-7.

Ministry of health and family welfare, GOI. Comprehensive abortion care 2010. Chapter 6, page 39-48.

Crenin MD, Grossman D. Medical management of first trimester abortion. ACOG Pract Bull. 2014;143:1-17.

Crenin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA. Randomised comparison of misoprostol 6-8 hrs versus 24 hrs after mifepristone for abortion. MOD study trial group. Obstet Gynecol. 2004;103(5 Pt 1):851-9.

Shi YE, Ye ZH, He CH, Zhang GQ, Xu JQ, Van Look PF, et al. Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception. 1993;48:133-49.

Swahn ML, Wang G, Aedo AR, Cekan SZ, Bygdeman M. Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception. 1986;34:469-81.

Guest J, Chien PF, Thomson MA, Kosseim ML. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG. 2007;114:207-15.

El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone and oral or vaginal misoprostol. N Engl J Med. 1995;332:983-7.

Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99:S160-7.

Shrivastava V. Safety efficacy and acceptability of medical abortion with mifepristone and misoprostol in Nepalese women. Nepal J Obstet Gynecol. 2007;2(2):54-8.

Coyaji K, Krishna U, Ambardekar S, Bracken H, Raote V, MAndlekar A et al. Are two doses of misoprostol after mifepristone for early abortion better than one? BJOG. 2007;114:271-8.

Urquhart DR, Templeton AA, Shinewi F, Chapman M, Hawkins K, McGarry J. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation: UK Multicentre Study- final results. Contraception. 1997;55:1-5.

Petron R, Auveny E, Targosz V. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993; 328:1509-13.

Spitz IM, Barbin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241-7.

World Health Task Force on post ovulatory methods of fertility regulation. Comparison of two doses of mifepristone in combination with misoprostol. 2000;107:524-30.

Ashok PW, Pnney GC, Flet GM, Templeton A. An effective regimen for early medical abortion: A report of 2000 consecutive cases. Hum Reprod. 1998;13:2962-5.

Royal College of Obstetricians and Gynecologist. The care of women requesting induced abortion. London: RCOG press; 2004.

Crenin, Schwartz, Pymar, Fink. Efficacy of mifepristone followed on the same day by misoprostol for early termination of pregnancy; report of a randomized trial. BJOG. 2001; 108(5):469-73.

Schaffea, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS et al. Vaginal misoprostol administered one two or three days after mifepritone for early medical abortion: A Randomised trial. JAMA. 2000;284:1948-53.

Crenin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA, et al. Mifepristone and misoprostol administered simultaneously versus 24 hrs apart for abortion :A randomized control trial. Obstet Gynecol. 2007;109:885-94.

Kathaleen K, Lesli M, Patrisia L, Mithcell D. Mifepristone and misoprostol for early pregnancy failure. Am J Obstet Gynecol. 2011;204(5):386.